29 Mar New Test Aims for Early Detection of Sepsis Utilizing Coagulation Factors

MedicalResearch.com Interview with:

Dr. Mahan

Michael J. Mahan Ph.D.
Professor
Dept of Molecular, Cellular, and Developmental Biology
University of California
Santa Barbara, CA

MedicalResearch.com:  What is the background for this study?  What are the main findings? 

Response:  Sepsis is the number one cause of death in US hospitals- but few molecular diagnostics and therapies exist for this condition. In the clinic, sepsis is diagnosed by a symptom-based approach that may include kidney or liver failure, blood clotting or bleeding — which is often well after permanent organ damage.

Thus, molecular diagnostics that detect infection at early stages of disease to minimize host injury are sorely needed.

MedicalResearch.com:  What are the main findings?

Response:     We have developed a new test that predicts sepsis soon after infection in mice — well before blood clotting and organ failure —enabling early sepsis treatment resulting in markedly increased survival. 

MedicalResearch.com: What should readers take away from your report?

Response:     The findings provide a platform to develop rapid and easy-to-perform clinical tests for early sepsis detection and clinical intervention in human patients.

Citation:

Coagulation factor protein abundance in the pre-septic state predicts coagulopathic activities that arise during late-stage murine sepsis
Heithoff, Douglas M. et al.
eBioMedicine, Volume 78, 103965

[wysija_form id=”3″]

[last-modified]

The information on MedicalResearch.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. Some links may be sponsored and no links are warranted or endorsed by MedicalResearch.com or its parent company, Eminent Domains Inc. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.

Last Updated on March 29, 2022 by Marie Benz MD FAAD